Skip to main content
SpringerLink
Log in

The pathogenesis of acute, latent and recurrent herpes simplex virus infections

  • Brief Review
  • Published:
Archives of Virology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Adam, E., Kaufman, R. H., Mirkovic, R. R., Melnick, J. L.: Persistence of virus shedding in asymptomatic women after recovery from herpes genitalis. Obstet. Gynecol.54, 171–173 (1979).

    Google Scholar 

  2. Armstrong, J. A., Evans, A. S., Rao, N., Ho, M.: Viral infections in renal transplant recipients. Infect. Immun.14, 970–975 (1976).

    Google Scholar 

  3. Babiuk, L. A., Rouse, B. T.: Immune control of herpesvirus latency. Can. J. Microbiol.25, 267–274 (1979).

    Google Scholar 

  4. Baringer, J. R.: Herpes simplex virus infection of nervous tissue in animals and man. Progr. Med. Virol.20, 1–26 (1975).

    Google Scholar 

  5. Baringer, J. R., Swoveland, P.: Persistent herpes simplex virus infection in rabbit trigeminal ganglia. Lab. Invest.30, 230–240 (1974).

    Google Scholar 

  6. Becker, Y., Hadar, J.: Antivirals 1980—An update. Prog. Med. Virol.26, 1–44 (1980).

    Google Scholar 

  7. Blyth, W. A., Hill, T. J., Field, H. J., Harbour, D. A.: Reactivation of herpes simplex virus infection by ultraviolet light and possible involvement of prostaglandins. J. Gen. Virol.33, 547–550 (1976).

    Google Scholar 

  8. Bodian, D.: The virus, the nerve cell, and paralysis. A study of experimental poliomyelitis in the spinal cord. Bull. Johns Hopkins Hosp.83, 1–108 (1948).

    Google Scholar 

  9. Brown, S. M., Subak,-Sharpe J. H., Warren, K. G., Wroblevska, Z., Koprowski, H.: Detection by complementation of defective or uninducible (herpes simplex virus type 1) virus genomes latent in human ganglia. Proc. Natl. Acad. Sci. U.S.A.76, 2364–2368 (1979).

    Google Scholar 

  10. Cappel, R., de Cuyper, F., Rickaert, F.: Efficacy of a nuclei acid free herpetic subunit vaccine. Arch. Virol.65, 15–24 (1980).

    Google Scholar 

  11. Cheeseman, S. H., Rubin, R. H., Stewart, J. A., Tolkoff-Rubin, N. E., Cosimi, A. B., Cantell, K., Gilbert, J., Winkle, S., Herrin, J. T., Black, P. S., Hirsch, M. S.: Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. New Engl. J. Med.300, 1345–1349 (1979).

    Google Scholar 

  12. Chou, S., Gallagher, T. G., Merrigan, T. C.: Controlled clinical trial of intravenous Acyclovir in hearttransplant patients with mucocutaneous herpes simplex infections. Lanceti, 1392–1394 (1981).

    Google Scholar 

  13. Cook, M. L., Stevens, J. G.: Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection. Infect. Immun.7, 272 to 288 (1973).

    Google Scholar 

  14. Cook, M. L., Stevens, J. G.: Latent herpetic infections following experimental viraemia. J. Gen. Virol.31, 75–80 (1976).

    Google Scholar 

  15. Courtney, R. J., Benyesh-Melnick, M.: Isolation and characterization of a large molecular weight polypeptide of herpes simplex virus type 1. Virology62, 539–551 (1974).

    Google Scholar 

  16. Craig, C. P., Nahmias, A. J.: Different patterns of neurologic involvement with herpes simplex virus type 1 and 2: isolation of herpes simplex virus type 2 from the buffy coat of two adults with meningitis. J. Infect. Dis.127, 365–372 (1973).

    Google Scholar 

  17. Cupps, T. R., Straus, S. E., Waldmann, T. A.: Successful treatment with Acyclovir of an immunodeficient patient infected simultaneously with multiple Herpesviruses. Amer. J. Med.70, 882–886 (1981).

    Google Scholar 

  18. Dixon, R. A. F., Schaffer, P. A.: Fine structure mapping and functional analysis of temperature-sensitive mutants in the gene encoding the herpes simplex virus type 1 immediate early protein VP 175. J. Virol.36, 189–203 (1980).

    Google Scholar 

  19. Docherty, J. J., Chopan, M.: The latent herpes simplex virus. Bact. Rev.38, 337–355 (1974).

    Google Scholar 

  20. Duff, R., Rapp, F.: Oncogenic transformation of hamster embryo cells after exposure to inactivated herpes simplex virus type 1. J. Virol.12, 209–217 (1973).

    Google Scholar 

  21. Field, H. J., Bell, S. E., Ellion, G. B., Nash, A. A., Wildy, P.: Effect of acycloguanosine treatment on acute and latent herpes simplex infections in mice. Antimicrob. Agents Chemother.15, 554–561 (1979).

    Google Scholar 

  22. Field, H. J., Darby, G.: Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovirin vitro andin vivo. Antimicrob. Agents Chemother.17, 209–216 (1980).

    Google Scholar 

  23. Field, H. J., Hill, T. J.: The pathogenesis of pseudorabies in mice following peripheral inoculation. J. Gen. Virol.23, 145–157 (1974).

    Google Scholar 

  24. Field, H. J., Wildy, P.: The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice. J. Hyg. Camb.81, 267–277 (1978).

    Google Scholar 

  25. Field, H. J., Wildy, P.: Recurrent herpes simplex: the outlook for systemic antiviral agents. Brit. Med. J.282, 1821–1822 (1981).

    Google Scholar 

  26. Fong, B. S., Scriba, M.: Use of [125I] deoxycytidine to detect herpes simplex virus-specific thymidine kinase in tissues of latently infected guinea pigs. J. Virol.34, 644–649 (1980).

    Google Scholar 

  27. Galasso, G. J.: An assessment of antiviral drugs for the management of infectious diseases in humans. Antiviral Res.1, 73–96 (1981).

    Google Scholar 

  28. Galloway, D. A., Fenoglio, C., Shevchuck, M., McDougall, J. K.: Detection of herpes simplex RNA in human sensory ganglia. Virology95, 265–268 (1979).

    Google Scholar 

  29. Goodman, E. L., Luby, J. P., Johnson, M. T.: Prospective double-blind evaluation of topical adenine arabinoside in male herpes progenitalis. Antimicrob. Agents Chemother.8, 693–697 (1975).

    Google Scholar 

  30. Goodpasture, E. W.: Herpetic infection, with especial reference to involvement of the nervous system. Medicine (Baltimore)8, 223–243 (1929).

    Google Scholar 

  31. Green, M. T., Courtney, R. J., Dunkel, E. C.: Detection of an immediate early herpes simplex virus type 1 polypeptide in trigeminal ganglia from latently infected animals. Infect. Immun.34, 987–992 (1981).

    Google Scholar 

  32. Green, M. T., Rosborough, J. P., Dunkel, E. C.:In vivo reactivation of herpes simplex virus in rabbit trigeminal ganglia: electrode model. Infect. Immun.34, 69–74 (1981).

    Google Scholar 

  33. Harbour, D. A., Blyth, W. A., Hill, T. J.: Prostaglandins enhance spread of herpes simplex virus in cell cultures. J. Gen. Virol.41, 87–95 (1978).

    Google Scholar 

  34. Hill, T. J., Blyth, W. A.: An alternative theory of herpes simplex recurrence and a possible role for prostaglandins. Lanceti, 397–399 (1976).

    Google Scholar 

  35. Hill, T. J., Harbour, D. A., Blyth, W. A.: Isolation of herpes simplex virus from the skin of clinically normal mice during latent infection. J. Gen. Virol.47, 205–207 (1980).

    Google Scholar 

  36. Hill, T. J., Field, H. J., Roome, A. P. C.: Intra-axonal location of herpes simplex virus particles. J. Gen. Virol.15, 253–255 (1972).

    Google Scholar 

  37. Hilleman, M. R., Larson, V. M., Lehman, E. D., Salerno, R. A., Conrad, P. G., McLean, A. A.: Subunit herpes simplex virus-2 vaccine. In:Nahmias, A. J., Dowdle, W. R., Schinazi, R. F. (eds.), The Human Herpesviruses, 503–506. New York: Elsevier 1981.

    Google Scholar 

  38. Honess, R. W., Roizmann, B.: Regulation of herpes virus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J. Virol.14, 8–19 (1974).

    Google Scholar 

  39. Juel-Jensen, B. E., MacCallum, F. O.: Treatment of herpes simplex lesions of the face with idoxuridine: results of a double-blind controlled trial. Brit. Med. J.ii, 987–988 (1964).

    Google Scholar 

  40. Kaufman, H. E.: Local theraphy of herpes simplex virus ocular infections. In:Nahmias, A. J., Dowdle, W. R., Schinazi, R. F. (eds.), The Human Herpesviruses, 466–477. New York: Elsevier 1981.

    Google Scholar 

  41. Kern, E. R., Overall, J. C., jr., Glasgow, L. A.: Herpesvirus hominis infection in newborn mice: comparison of the therapeutic efficacy of 1-B-D-arabinofuranosycytosine and 9-B-D-arabinofuranosyladenine. Antimicrob. Agents Chemother.7, 587–595 (1975).

    Google Scholar 

  42. Kitces, E. N., Morahan, P. S., Twe, J. G., Murray, B. K.: Protection from oral herpes simplex infection by a nucleic acid-free virus vaccine. Infect. Immun.16, 955–960 (1977).

    Google Scholar 

  43. Klein, R. J.: Pathogenetic mechanisms of recurrent herpes simplex virus infections. Arch. Virol.51, 1–13 (1976).

    Google Scholar 

  44. Klein, R. J.: Effect of immune serum on the establishment of herpes simplex virus infection in trigeminal ganglia of hairless mice. J. Gen. Virol.49, 401–405 (1980).

    Google Scholar 

  45. Klein, R. J., Buimovici-Klein, E., Moser, H., Moucha, R., Hilfenhaus, J.: Efficacy of a virion envelope herpes simplex virus vaccine against experimental skin infections in hairless mice. Arch. Virol.68, 73–80 (1981).

    Google Scholar 

  46. Klein, R. J., DeStefano, E.: The initiation of the acute herpes simplex virus infection in mice. In preparation (1982).

  47. Klein, R. J., DeStefano, E., Brady, E., Friedman-Kien, A. E.: Experimental skin infection with an acyclovir-resistant herpes simplex virus mutant: response to antiviral treatment and protection against reinfection. Arch. Virol.65, 237–246 (1980).

    Google Scholar 

  48. Klein, R. J., DeStefano, E., Friedman-Kien, A. E., Brady, E.: Effect of acyclovir on latent herpes simplex virus infections in trigeminal ganglia of mice. Antimicrob. Agents Chemother.19, 937–939 (1981).

    Google Scholar 

  49. Klein, R. J., Friedman-Kien, A. E.: Latent herpes simplex virus infections in spinal ganglia of mice after treatment with adenine arabinoside and adenine arabinoside monophophosphate. Antimicrob. Agents Chemother.12, 577–581 (1977).

    Google Scholar 

  50. Klein, R. J., Friedman-Kien, A. E., Brady, E.: Latent herpes simplex virus in ganglia of mice after primary infection and reinoculation at a distant site. Arch. Virol.57, 161–166 (1978).

    Google Scholar 

  51. Klein, R. J., Friedman-Kien, A. E., DeStefano, E.: Pathogenesis of experimental skin infections induced by drug-resistant herpes simplex virus mutants. Infect. Immun.34, 693–701 (1981).

    Google Scholar 

  52. Klein, R. J., Friedman-Kien, A. E., Yellin, P. B.: Orofacial herpes simplex virus infection in hairless mice: latent virus in trigeminal ganglia after topical antiviral treatment. Infect. Immun.20, 130–135 (1978).

    Google Scholar 

  53. Knotts, I. B., Cook, M. L., Stevens, J. G.: Pathogenesis of herpetic encephalitis in mice after ophthalmic inoculation. J. Infect. Dis.130, 16–27 (1974).

    Google Scholar 

  54. Korsager, B., Spencer, E. S., Mardhorst, C. H., Andersen, H. K.: Herpes-virus hominis infections in renal transplant recipients. Scand. J. Inf. Dis.7, 11–19 (1975).

    Google Scholar 

  55. Kristensson, K., Ghetti, B., Wisniewski, H. M.: Study on the propagation of herpes simplex virus (type 2) into the brain after intraocular injection. Brain Res.69, 189–201 (1974).

    Google Scholar 

  56. Kristensson, K., Lycke, E., Sjostrand, J.: Spread of herpes simplex virus in peripheral nerves. Acta Neuropath.17, 44–53 (1971).

    Google Scholar 

  57. Kristensson, K., Vahlne, A., Persson, L. A., Lycke, E.: Neural spread of herpes simplex virus types 1 and 2 in mice after corneal or subcutaneous (footpad) inoculation. J. Neurol. Sci.35, 331–340 (1978).

    Google Scholar 

  58. Kurata, T., Kurata, K., Aoyama, Y.: Reactivation of herpes simplex virus (type 2) infection in trigeminal ganglia and oral lips with cyclophosphamide treatment. Japan. J. Exp. Med.48, 427–435 (1978).

    Google Scholar 

  59. Kutinova, L., Slichtova, V., Vonka, V.: Immunogenicity of subviral herpes simplex virus preparations. Arch. Virol.61, 141–148 (1979).

    Google Scholar 

  60. Kwon, B. S., Gangarosa, L. P., Burch, K. D., de Back, J., Hill, J. M.: Induction of ocular herpes simplex virus shedding by iontophoresis of epinephrine into rabbit cornea. Invest. Ophthalmol. Vis. Sci.21, 442–449 (1981).

    Google Scholar 

  61. Lascano, E. F., Berria, M. I.: Histological study of the progression of herpes simplex virus in mice. Arch. Virol.64, 67–79 (1980).

    Google Scholar 

  62. Lofgren, K. W., Stevens, J. G., Marsden, H. S., Subak-Sharpe, J. H.: Temperature-sensitive mutants of herpes simplex virus differ in the capacitiy to establish latent infections in mice. Virology76, 440–443 (1977).

    Google Scholar 

  63. MacCallum, F. O., Juel-Jensen, B. E.: Herpes simplex virus skin infection in man treated with idoxuridine in dimethyl sulfoxide: results of a double blind-controlled trial. Brit. Med. J.ii, 805–807 (1966).

    Google Scholar 

  64. McLennan, J. L., Darby, G.: Herpes simplex virus latency: the cellular location of virus in dorsal root ganglia and the fate of the infected cell following virus activation. J. Gen. Virol.51, 233–243 (1980).

    Google Scholar 

  65. Mertin, J., Stackpole, A.: Anti-PGE antibodies inhibitin vivo development of cell-mediated immunity. Nature294, 456–458 (1981).

    Google Scholar 

  66. Mitchell, C. D., Bean, B., Gentry, S., Groth, K. E., Boen, J. R., Balfour, H. H., Jr.: Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients. Lanceti, 1389–1392 (1981).

    Google Scholar 

  67. Montgomerie, J. Z., Becroft, D. M. O., Crotson, M. C., Doak, P. B., North, J. D. K.: Herpes simplex virus infection after renal transplantation. Lancetii, 867–871 (1969).

    Google Scholar 

  68. Moreschi, G. I., Ennis, F. A.: Prevention of herpes simplex virus infections. In:Nahmias, A. J., Dowdle, W. R., Schinazi, R. F. (eds.), The Human Herpesviruses, 441–446. New York: Elsevier 1981.

    Google Scholar 

  69. Myers, M. G., Oxman, M. N., Clark, J. E., Arndt, K. A.: Failure of neutralred photodynamic inactivation in recurrent herpes simplex virus infections. New Engl. J. Med.293, 945–949 (1975).

    Google Scholar 

  70. Nagafuchi, S., Oda, H., Mori, R., Taniguchi, T.: Mechanism of acquired resistance to herpes simplex virus infection as studied in nude mice. J. Gen. Virol.44, 715–723 (1979).

    Google Scholar 

  71. Nahmias, A. J.: Herpes viruses from fish to man. A search for pathobiologic unity. In:Joachim, H. (ed.), Pathobiology Annual, 153–182. New York: Century Crofts 1972.

    Google Scholar 

  72. Nahmias, A. J., Roizman, B.: Infection with herpes simplex viruses 1 and 2. New Engl. J. Med.289, 667–674; 719–725; 781–789 (1973).

    Google Scholar 

  73. Naraqi, S., Jackson, G. G., Jonasson, O. M.: Viremia with herpes simplex type 1 in adults. Four nonfatal cases, one with features of chicken pox. Ann. Int. Med.85, 165–169 (1976).

    Google Scholar 

  74. Naraqi, S., Jackson, G. G., Jonasson, O., Yamashiroya, H. M.: Prospective study of prevalence, incidence and source of herpesvirus infections in patients with renal allografts. J. Inf. Dis.136, 531–540 (1977).

    Google Scholar 

  75. Nesburn, A. B., Dickinson, R., Radnoti, M.: The effect of trigeminal nerve and ganglion manipulation on recurrence of ocular herpes simplex in rabbits. Invest. Ophthalmol.15, 726–731 (1976).

    Google Scholar 

  76. Ohashi, Y., Sakaue, Y., Kato, S., Wada, T., Sato, K.: A detergent-soluble extract of virus infected cells free from infectious virus protects mice from lethal herpes simplex virus infection. Biken J.23, 199–204 (1980).

    Google Scholar 

  77. Openshaw, H., Puga, A., Notkins, A. L.: Herpes simplex virus infection in sensory ganglia: immune control, latency, and reactivation. Fed. Proc.38, 2660 to 2664 (1979).

    Google Scholar 

  78. Openshaw, H., Sekizawa, T., Wohlenberg, C., Notkins, A. B.: The role of immunity in latency and reactivation of herpes simplex viruses. In:Nahmias, A. J., Dowdle, W. R., Schinazi, R. F. (eds.), The Human Herpesviruses, 289–296. New York: Elsevier 1981.

    Google Scholar 

  79. Overall, J. C., Jr.: Dermatologic diseases. In:Galasso, G. J., Merigan, T. C. (eds.), Antiviral Agents and Viral Diseases of Man, 305–384. New York: Raven Press 1979.

    Google Scholar 

  80. Paine, T. F., Jr.: Latent herpes simplex infection in man. Bact. Rev.28, 472–479 (1964).

    Google Scholar 

  81. Pass, R. W., Whitley, R. J., Whelchel, J. D., Diethelm, A. G., Reynolds, D. W., Alford, C. A.: Identification of patients with increased risk of infection with herpes simplex virus after renal transplantation. J. Inf. Dis.140, 487–492 (1979).

    Google Scholar 

  82. Pavan-Langston, D., Park, N. H., Hettinger, M.: Ganglionic herpes simplex and systemic acyclovir. Arch. Ophthalmol.99, 1417–1419 (1981).

    Google Scholar 

  83. Pazin, G. J., Armstrong, J. A., Lam, M. T., Tarr, G. C., Janetta, P. J., Ho, M.: Prevention of reactivated herpes simplex infection by human leukocyte interferon. New Engl. J. Med.301, 225–230 (1979).

    Google Scholar 

  84. Pazin, J. P., Ho, M., Janetta, P. J.: Reactivation of herpes simplex virus after decompression of the trigeminal nerve root. J. Inf. Dis.138, 405–409 (1978).

    Google Scholar 

  85. Pien, F. D., Smith, T. F., Anderson, C. F., Webel, M. L., Taswell, H. F.: Herpesvirus in renal transplant patients. Transplantation16, 489–495 (1973).

    Google Scholar 

  86. Price, R. W., Khan, A.: Resistance of peripheral autonomic neurons toin vivo productive infection by herpes simplex virus mutants deficient in thymidine kinase activity. Infect. Immun.34, 571–580 (1981).

    Google Scholar 

  87. Price, R. W., Schmitz, J.: Reactivation of latent herpes simplex virus infection of the autonomic nervous system by postganglionic neurectomy. Infect. Immun.19, 523–532 (1978).

    Google Scholar 

  88. Puga, A., Rosenthal, J. D., Openshaw, H., Notkins, A. L.: Herpes simplex virus DNA and mRNA sequences in acutely and chronically infected trigeminal ganglia of mice. Virology89, 102–111 (1978).

    Google Scholar 

  89. Rajcani, J., Kutinova, L., Vonka, V.: Restriction of latent herpes simplex virus infection in rabbits immunized with subviral herpes simplex vaccine. Acta Virol.24, 183–193 (1980).

    Google Scholar 

  90. Rand, K. H., Rasmussen, L. E., Pollard, R. B., Arvin, A., Merigan, T. C.: Cellular immunity and herpesvirus infections in cardiac-transplant patients. New Engl. J. Med.296, 1372–1377 (1977).

    Google Scholar 

  91. Reeves, W. C., Corey, L., Adams, H. G., Vontver, L. A., Holmes, K. K.: Risk of recurrence after first episode of genital herpes. Relation to HSV type and antibody response. New Engl. J. Med.305, 315–319 (1981).

    Google Scholar 

  92. Renis, H. E., Eidson, E. A., Mathews, J., Gray, J. E.: Pathogenesis of herpes simplex virus types 1 and 2 in mice after various routes of inoculation. Infect. Immun.14, 571–578 (1976).

    Google Scholar 

  93. Ritchie, D. A., Timbury, M. C.: Herpes viruses and latency: possible relevance of the structure of the viral genome. FEBS Microbiol. Letters9, 67–72 (1980).

    Google Scholar 

  94. Roizman, B.: An inquiry into the mechanism of recurrent herpes infections of man. Perspect. Virol.4, 283–301 (1965).

    Google Scholar 

  95. Rouse, B. T., Babiuk, L. A.: Mechanism of recovery from herpesvirus infections. A review. Can. J. Compar. Med.42, 414–427 (1978).

    Google Scholar 

  96. Rowe, N. H., Brooks, S. L., Young, S. K., Spencer, J., Petrick, T. J., Buchanan, R. A., Drach, J. C., Shipman, C.: A clinical trial of topically applied 3 percent vidarabine against recurrent herpes labials. Oral Surg. Oral Med. Oral Path.47, 142–147 (1979).

    Google Scholar 

  97. Saral, R., Burns, W. H., Laskin, O. L., Santos, G. W., Lietman, P. S.: Acyclovir prophylaxis of herpes simplex virus infections. A randomized double-blind, controlled trial in bone-marrow transplant recipients. New Engl. J. Med.305, 63–67 (1981).

    Google Scholar 

  98. Schwartz, J., Whetsell, W. O., Elizan, T. S.: Latent herpes simplex virus infection of mice: infectoius virus in homogenates of latently infected dorsal root ganglia. J. Neuropathol. Exp. Neurol.37, 45–55 (1978).

    Google Scholar 

  99. Scriba, M.: Extraneural localization of herpes simplex virus in latently infected guinea pigs. Nature267, 529–531 (1977).

    Google Scholar 

  100. Scriba, M.: Persistence of herpes simplex virus (HSV) infection in ganglia and peripheral tissue of guinea pigs. Med. Microbiol. Immunol.169, 91–96 (1981).

    Google Scholar 

  101. Scriba, M., Tatzber, F.: Pathogenesis of herpes simplex virus infections in guinea pigs. Infect. Immun.34, 655–661 (1981).

    Google Scholar 

  102. Sekizawa, T., Openshaw, H., Wohlenberg, C., Notkins, A. L.: Latency of herpes simplex virus in absence of neutralizing antibody: model for reactivation. Science210, 1026–1028 (1980).

    Google Scholar 

  103. Smith, R. A., Sidwell, R. W., Robins, R. K.: Antiviral mechanisms of action. Ann. Rev. Pharmacol. Toxicol.20, 259–284 (1980).

    Google Scholar 

  104. Spruance, S. L., Crumpacker, C. S., Haines, H., Bader, C., Mehr, K., MacCalman, J., Schnipper, L. E., Klauber, M, R., Overall, J. C., jr.: Ineffectiveness of topical arabinoside 5′-monophosphate in the treatment of recurrent herpes simplex labialis. New Engl. J. Med.300, 1180–1184 (1979).

    Google Scholar 

  105. Stevens, J. G.: Latent characteristics of selected herpesviruses. Adv. Canc. Res.22, 227–256 (1977).

    Google Scholar 

  106. Stevens, J. G., Cook, M. L.: Latent herpes simplex virus in spinal ganglia of mice. Science173, 843–845 (1971).

    Google Scholar 

  107. Stevens, J. G., Nesburn, A. B., Cook, M. L.: Latent herpes simplex virus from trigeminal ganglia of rabbits with recurrent eye infection. Nature (New Biol.)235, 216–271 (1972).

    Google Scholar 

  108. Svennerholm, B., Vahlne, A., Lycke, E.: Persistent reactivable latent herpes simplex virus infection in trigeminal ganglia of mice treated with antiviral drugs. Arch. Virol.69, 43–48 (1981).

    Google Scholar 

  109. Tenser, R. B., Dunstan, M. E.: Herpes simplex virus thymidine kinase expression in the infection of the trigeminal ganglion. Virology99, 417–422 (1979).

    Google Scholar 

  110. Tenser, R. B., Miller, R. L., Rapp, F.: Trigeminal ganglion infection by thymidine kinase negative-mutants of herpes simplex virus. Science205, 915–917 (1979).

    Google Scholar 

  111. Tenser, R. B., Ressel, S., Dunstan, M. E.: Herpes simplex virus thymidine kinase expression in trigeminal ganglion infection: correlation of enzyme activity with ganglion virus titers and evidence forin vivo complementation. Virology112, 328–341 (1981).

    Google Scholar 

  112. Thompson, T. A., Murray, B. K., Morahan, P. S., Cline, P., and the Collaborative Study Group: Protective studies on several herpes simplex type 1 vaccine preparations in a mouse labial infection model (Abstract) In:Nahmias, A. J., Dowdle, W. R., Schinazi, R. F. (eds.), The Human Herpesviruses, 649–650. New York: Elsevier 1981.

    Google Scholar 

  113. Trousdale, M. D., Dunkel, E. C., Nesburn, A. B.: Effect of acyclovir on acute and latent herpes simplex virus infections in the rabbit. Invest. Ophthalmol. Vis. Sci.19, 1336–1341 (1980).

    Google Scholar 

  114. Walz, M. A., Price, R. W., Notkins, A. L.: Latent infection with herpes simplex virus types 1 and 2: viral reactivationin vivo after neurectomy. Science184, 1185–1187 (1974).

    Google Scholar 

  115. Walz, M. A., Yamamoto, H., Notkins, A. L.: Immunological response restricts number of cells in sensory ganglia infected with herpes simplex virus. Nature264, 554–556 (1976).

    Google Scholar 

  116. Watson, K., Stevens, J. G., Cook, M. L., Subak-Sharpe, J. H.: Latency competence of thirteen HSV-1 temperature-sensitive mutants. J. Gen. Virol.49, 149–159 (1980).

    Google Scholar 

  117. Wheeler, C. E.: Pathogenesis of recurrent herpes simplex infections. J. Invest. Dermatol.65, 341–346 (1975).

    Google Scholar 

  118. Whitley, R. J., Alford, C. A.: Developmental aspects of selected antiviral chemotherapeutic agents. Ann. Rev. Microbiol.32, 285–300 (1978).

    Google Scholar 

  119. Whitley, R. J., Nahmias, A. J., Visintine, A. M., Fleming, C. L., Alford, C. A.: The natural history of herpes simplex virus infection of mother and newborn. Pediatrics66, 489–494 (1980).

    Google Scholar 

  120. Whitley, R. J., Soong, S. J., Dolin, R., Galasso, G. J., Ch'ien, L. T., Alford, C. A., and the Collaborative Study Group: Adenine arabinoside therapy of biopsyproved herpes simplex encephalitis. New Engl. J. Med.297, 289–294 (1977).

    Google Scholar 

  121. Wildy, P.: The progression of herpes simplex virus to the central nervous system of the mouse. J. Hyg. Camb.65, 173–192 (1967).

    Google Scholar 

  122. Yamamoto, H., Walz, M. A., Notkins, A. L.: Viral-specific thymidine kinase in sensory ganglia of mice infected with herpes simplex virus. Virology76, 866 to 869 (1977).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology, New York University Medical Center, New York, N.Y., USA

    R. J. Klein

Authors
  1. R. J. Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

With 4 Figures

Rights and permissions

Reprints and permissions

About this article

Cite this article

Klein, R.J. The pathogenesis of acute, latent and recurrent herpes simplex virus infections. Archives of Virology 72, 143–168 (1982). https://doi.org/10.1007/BF01348961

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01348961

Keywords

Search

Navigation